Literature DB >> 10386630

What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy.

G M Duchesne, L J Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10386630     DOI： 10.1016/s0360-3016(99)00024-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  33 in total

Review 1.  Exploring two two-edged swords.

Authors:  David J Brenner
Journal:  Radiat Res       Date:  2012-06-27       Impact factor: 2.841

Review 2.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

3.  Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.

Authors:  I-Chow Hsu; Kyounghwa Bae; Katsuto Shinohara; Jean Pouliot; James Purdy; Geoffrey Ibbott; Joycelyn Speight; Eric Vigneault; Robert Ivker; Howard Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-06       Impact factor: 7.038

4.  High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: results of a retrospective analysis.

Authors:  Ryoong-Jin Oh; Yasuo Yoshioka; Eiichi Tanaka; Hiroya Shiomi; Iori Sumida; Fumiaki Isohashi; Osamu Suzuki; Koji Konishi; Yoshifumi Kawaguchi; Satoaki Nakamura; Masahiro Kato; Takehiro Inoue
Journal:  Radiat Med       Date:  2006-01

Review 5.  [Curative radiotherapy of localized prostate cancer. Treatment methods and results].

Authors:  R Schwarz
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

6.  Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  Alan Pollack; Gail Walker; Eric M Horwitz; Robert Price; Steven Feigenberg; Andre A Konski; Radka Stoyanova; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; Charlie Ma; Mark K Buyyounouski
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

Review 7.  Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy.

Authors:  Scott G Williams; Anthony L Zietman
Journal:  World J Urol       Date:  2008-09-07       Impact factor: 4.226

8.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

Authors:  David J Brenner
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

9.  Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Authors:  Mark Ritter
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

10.  Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.

Authors:  Simona Marzi; Biancamaria Saracino; Maria G Petrongari; Stefano Arcangeli; Sara Gomellini; Giorgio Arcangeli; Marcello Benassi; Valeria Landoni
Journal:  J Exp Clin Cancer Res       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.